Efficacy of trovafloxacin (TROVA), a new quinolone agent with potent gram-positive activity, in experimental staphylococcal endocarditis (IE) due to methicillin-resistant strains: 268

A. S. Bayer; C. Li; M. Ing

doi:10.1086/514522

Efficacy of trovafloxacin (TROVA), a new quinolone agent with potent gram-positive activity, in experimental staphylococcal endocarditis (IE) due to methicillin-resistant strains: 268

A. S. Bayer
, C. Li
, M. Ing

Research output: Contribution to journal › Meeting abstract › peer-review

Original language	English
Pages (from-to)	405
Number of pages	1
Journal	Clinical Infectious Diseases
Volume	25
Issue number	2
DOIs	https://doi.org/10.1086/514522
State	Published - 1997
Externally published	Yes

ASJC Scopus Subject Areas

Microbiology (medical)
Infectious Diseases

Access to Document

10.1086/514522

OpenUrl availability

Full text

Cite this

@article{b8eaed2e191f45a288e2d22d383aef30,

title = "Efficacy of trovafloxacin (TROVA), a new quinolone agent with potent gram-positive activity, in experimental staphylococcal endocarditis (IE) due to methicillin-resistant strains: 268",

author = "Bayer, \{A. S.\} and C. Li and M. Ing",

year = "1997",

doi = "10.1086/514522",

language = "English",

volume = "25",

pages = "405",

journal = "Clinical Infectious Diseases",

issn = "1058-4838",

number = "2",

}

TY - JOUR

T1 - Efficacy of trovafloxacin (TROVA), a new quinolone agent with potent gram-positive activity, in experimental staphylococcal endocarditis (IE) due to methicillin-resistant strains

T2 - 268

AU - Bayer, A. S.

AU - Li, C.

AU - Ing, M.

PY - 1997

Y1 - 1997

UR - https://www.scopus.com/pages/publications/33748202096

UR - https://www.scopus.com/pages/publications/33748202096#tab=citedBy

U2 - 10.1086/514522

DO - 10.1086/514522

M3 - Meeting abstract

AN - SCOPUS:33748202096

SN - 1058-4838

VL - 25

SP - 405

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

IS - 2

ER -

Efficacy of trovafloxacin (TROVA), a new quinolone agent with potent gram-positive activity, in experimental staphylococcal endocarditis (IE) due to methicillin-resistant strains: 268

ASJC Scopus Subject Areas

Access to Document

OpenUrl availability

Other files and links

Cite this